Form 4: Eli Lilly Director Acquires Shares Through Deferral Plan

Director Ralph Alvarez acquired 16 shares of Eli Lilly common stock through a deferral plan, increasing his total holdings to 54,029 shares.

Summary

• Ralph Alvarez, a director at Eli Lilly & Co, acquired 16 shares of common stock on April 15, 2024.
• The shares were acquired at a price of $750.77 per share.
• This transaction was part of the Lilly Directors' Deferral Plan, where the shares are deferred in lieu of cash compensation.
• The acquired shares will be settled in common stock after Mr. Alvarez's separation from service.
• Following this transaction, Mr. Alvarez's total direct holdings in Eli Lilly common stock increased to 54,029 shares.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to director compensation, which is generally viewed positively as it aligns director interests with shareholders. There is no indication of any negative sentiment.

Positives

• The acquisition of shares by a director can be seen as a positive sign of confidence in the company's future.

Future Outlook

The acquired shares will be settled in common stock following the reporting person's separation from service.

Industry Context

This is a routine filing related to director compensation and is common practice for publicly traded companies.

Comparison to Industry Standards

• Director share acquisitions through deferral plans are a common practice among large publicly traded companies, such as those in the pharmaceutical sector like Pfizer (PFE) and Johnson & Johnson (JNJ).
• These plans are often used to align the interests of directors with those of shareholders, and the deferral of shares until separation from service is a typical feature.
• The number of shares acquired in this transaction is relatively small compared to the total outstanding shares of Eli Lilly, and is not unusual for director compensation.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it demonstrates director confidence in the company.

Key Dates

Keywords

Eli Lilly, LLY, Director, Share Acquisition, Deferral Plan, Stock Ownership, Form 4, Insider Trading